2022 annual financial data
PTC Therapeutics 2022 Operating margin
PTC Therapeutics 2022 operating margin with verified reported values.
Direct answer
Operating margin was -64.03%.
Operating income was -447,409,000 USD and net income was -559,017,000 USD.
Operating cash flow was -356,654,000 USD.
Get free PTC Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 698,801,000 USD
- Operating income
- -447,409,000 USD
- Net income
- -559,017,000 USD
- Operating cash flow
- -356,654,000 USD